These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19347289)

  • 1. Molecular basis of histone deacetylase inhibitors as new drugs for the treatment of inflammatory diseases and cancer.
    Glauben R; Siegmund B
    Methods Mol Biol; 2009; 512():365-76. PubMed ID: 19347289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC inhibitors in models of inflammation-related tumorigenesis.
    Glauben R; Sonnenberg E; Zeitz M; Siegmund B
    Cancer Lett; 2009 Aug; 280(2):154-9. PubMed ID: 19101082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors: multifunctional anticancer agents.
    Liu T; Kuljaca S; Tee A; Marshall GM
    Cancer Treat Rev; 2006 May; 32(3):157-65. PubMed ID: 16516391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.
    Liu T; Liu PY; Tee AE; Haber M; Norris MD; Gleave ME; Marshall GM
    Eur J Cancer; 2009 Jul; 45(10):1846-54. PubMed ID: 19342222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways.
    Hwang JJ; Kim YS; Kim MJ; Jang S; Lee JH; Choi J; Ro S; Hyun YL; Lee JS; Kim CS
    Anticancer Drugs; 2009 Oct; 20(9):815-21. PubMed ID: 19644355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting histone deacetylases for the treatment of cancer and inflammatory diseases.
    Huang L
    J Cell Physiol; 2006 Dec; 209(3):611-6. PubMed ID: 17001696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors--turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases.
    Riester D; Hildmann C; Schwienhorst A
    Appl Microbiol Biotechnol; 2007 Jun; 75(3):499-514. PubMed ID: 17377788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.
    Frew AJ; Johnstone RW; Bolden JE
    Cancer Lett; 2009 Aug; 280(2):125-33. PubMed ID: 19359091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity.
    Perrino E; Cappelletti G; Tazzari V; Giavini E; Del Soldato P; Sparatore A
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1893-7. PubMed ID: 18294844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?
    Blanchard F; Chipoy C
    Drug Discov Today; 2005 Feb; 10(3):197-204. PubMed ID: 15708534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of resistance to histone deacetylase inhibitors and their therapeutic implications.
    Fantin VR; Richon VM
    Clin Cancer Res; 2007 Dec; 13(24):7237-42. PubMed ID: 18094401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review).
    Emanuele S; Lauricella M; Tesoriere G
    Int J Oncol; 2008 Oct; 33(4):637-46. PubMed ID: 18813776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
    Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2008 Jan; 21(1):109-15. PubMed ID: 18097623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors as novel anti-inflammatory agents.
    Adcock IM
    Curr Opin Investig Drugs; 2006 Nov; 7(11):966-73. PubMed ID: 17117583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
    Savickiene J; Treigyte G; Magnusson KE; Navakauskiene R
    Ann N Y Acad Sci; 2009 Aug; 1171():321-33. PubMed ID: 19723072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer.
    López-Soto A; Folgueras AR; Seto E; Gonzalez S
    Oncogene; 2009 Jun; 28(25):2370-82. PubMed ID: 19430493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells.
    Sonnemann J; Hüls I; Sigler M; Palani CD; Hong le TT; Völker U; Kroemer HK; Beck JF
    Oncol Rep; 2008 Jul; 20(1):219-24. PubMed ID: 18575740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
    Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMullan C; Miller JW; Marks PA; Mitsiades N
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4072-9. PubMed ID: 19387079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
    Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.